Investigating Endocannabinoid System in Social Anxiety Disorder

Stefan Kloiber M.D.
CAMH, Department of Psychiatry, Pharmacology and Toxicology, University of Toronto
Tuesday, February 20, 2024 - 3:00pm
MSB 2172
Departmental Seminar
Medical and Psychiatry training at University of Regensburg and Max-Planck-Institute of Psychiatry in Germany Research Scholarship, Scientist and Senior Physician at Max-Planck-Institute of Psychiatry in Germany In 2016 - joined University of Toronto and CAMH Current Positions: Senior Scientist, Psychiatrist, Medical Head General Adult Psychiatry and Health Systems Ambulatory Services, Access CAMH, and Ontario Structured Psychotherapy Program (OSP) at CAMH Associate Professor, Department of Psychiatry, University of Toronto Graduate Faculty appointments: Institute of Medical Science, Department of Pharmacology and Toxicology, and Collaborative Program in Neuroscience (CPIN) at University of Toronto Focus of Clinical and Scientific Work: Clinical research and PET imaging studies of Endocannabinoid System and Effects of Cannabinoids in Mood and Anxiety Disorders Clinical trials, Biomarker research, and QI in Mood and Anxiety Disorders
Department of Pharmacology & Toxicology
Pharmacology and Toxicology Seminar